Literature DB >> 22422892

Recurrent stroke on imaging and presumed paradoxical embolism: a cross-sectional analysis.

Georgios D Kitsios1, Aaron Lasker, Jasmeet Singh, David E Thaler.   

Abstract

OBJECTIVE: To identify whether factors supporting a diagnosis of paradoxical embolism (i.e., venous thrombosis or Valsalva maneuver) are associated with radiologic markers of recurrent strokes in patients with patent foramen ovale (PFO) and cryptogenic stroke (CS). Such clinical indicators of paradoxical embolism are commonly viewed as risk factors for CS recurrence, but precise risk estimates are lacking.
METHODS: Data from the prospective Tufts PFO Registry collected at the time of the index CS were analyzed. We defined the following radiologic markers of stroke recurrence: 1) strokes of different radiologic ages and 2) silent strokes (detected on MRI but without symptoms preceding the index event). We examined the association between the radiologic endpoints and the clinical indicators of paradoxical embolism with multivariate logistic regression models, adjusting for age and gender.
RESULTS: Data were available for 224 subjects. Strokes of different radiologic ages were not associated with the thrombosis-predisposing conditions (1.2 [95% confidence interval 0.5-2.7]), the Valsalva maneuver (1.3 [0.6-3.1]), or the presence of either of these factors. No statistically significant association was found in subgroups stratified by anatomic location of the index stroke or for the outcome of silent strokes.
CONCLUSIONS: Our negative findings do not lend support to using the presence of clinical indicators of paradoxical embolism as an indication for percutaneous PFO closure. Factors that support a paradoxical embolism mechanism may be different from those that predict paradoxical embolism recurrence. Further investigations with clinical follow-up and larger sample sizes are needed to reach more precise estimates for the associations examined.

Entities:  

Mesh:

Year:  2012        PMID: 22422892      PMCID: PMC3310316          DOI: 10.1212/WNL.0b013e31824d58bc

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

1.  Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause.

Authors:  K Berthet; T Lavergne; A Cohen; L Guize; M G Bousser; J Y Le Heuzey; P Amarenco
Journal:  Stroke       Date:  2000-02       Impact factor: 7.914

Review 2.  Indications for the closure of patent foramen ovale.

Authors:  Michael J Landzberg; Paul Khairy
Journal:  Heart       Date:  2004-02       Impact factor: 5.994

3.  Closure of patent foramen ovale after cryptogenic stroke.

Authors:  Jochen Wöhrle
Journal:  Lancet       Date:  2006-07-29       Impact factor: 79.321

4.  Risk of patent foramen ovale for thromboembolic events in all age groups.

Authors:  M A de Belder; L Tourikis; G Leech; A J Camm
Journal:  Am J Cardiol       Date:  1992-05-15       Impact factor: 2.778

5.  Improved morphologic characterization of atrial septal aneurysm by transesophageal echocardiography: relation to cerebrovascular events.

Authors:  B Schneider; P Hanrath; P Vogel; T Meinertz
Journal:  J Am Coll Cardiol       Date:  1990-10       Impact factor: 24.094

6.  Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies.

Authors:  J R Overell; I Bone; K R Lees
Journal:  Neurology       Date:  2000-10-24       Impact factor: 9.910

Review 7.  Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review.

Authors:  Paul Khairy; Clare P O'Donnell; Michael J Landzberg
Journal:  Ann Intern Med       Date:  2003-11-04       Impact factor: 25.391

8.  Atrial septal aneurysm in adult patients. A multicenter study using transthoracic and transesophageal echocardiography.

Authors:  A Mügge; W G Daniel; C Angermann; C Spes; B K Khandheria; I Kronzon; R S Freedberg; A Keren; K Denning; R Engberding
Journal:  Circulation       Date:  1995-06-01       Impact factor: 29.690

9.  Patent foramen ovale in cryptogenic stroke: incidental or pathogenic?

Authors:  Alawi A Alsheikh-Ali; David E Thaler; David M Kent
Journal:  Stroke       Date:  2009-05-14       Impact factor: 7.914

10.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

View more
  10 in total

1.  The Role of Patent Foramen Ovale in Cryptogenic Stroke.

Authors:  Songül Şenadim; Dilek Bozkurt; Murat Çabalar; Arsida Bajrami; Vildan Yayla
Journal:  Noro Psikiyatr Ars       Date:  2016-03-01       Impact factor: 1.339

Review 2.  Cryptogenic stroke: how to define it? How to treat it?

Authors:  Ava L Liberman; Shyam Prabhakaran
Journal:  Curr Cardiol Rep       Date:  2013-12       Impact factor: 2.931

Review 3.  Silent cerebral infarcts associated with cardiac disease and procedures.

Authors:  Mariëlla E C Hassell; Robin Nijveldt; Yvo B W Roos; Charles B L Majoie; Martial Hamon; Jan J Piek; Ronak Delewi
Journal:  Nat Rev Cardiol       Date:  2013-10-29       Impact factor: 32.419

Review 4.  Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis.

Authors:  David M Kent; Issa J Dahabreh; Robin Ruthazer; Anthony J Furlan; Christian Weimar; Joaquín Serena; Bernhard Meier; Heinrich P Mattle; Emanuele Di Angelantonio; Maurizio Paciaroni; Herwig Schuchlenz; Shunichi Homma; Jennifer S Lutz; David E Thaler
Journal:  Eur Heart J       Date:  2015-07-03       Impact factor: 29.983

Review 5.  Patent Foramen Ovale and Stroke-Current Status.

Authors:  Oh Young Bang; Mi Ji Lee; Sookyung Ryoo; Suk Jae Kim; Ji Won Kim
Journal:  J Stroke       Date:  2015-09-30       Impact factor: 6.967

6.  Association of Left Atrial Enlargement with Cortical Infarction in Subjects with Patent Foramen Ovale.

Authors:  Mi Ji Lee; Sung-Ji Park; Chang Hyo Yoon; Ji-Won Hwang; Sookyung Ryoo; Suk Jae Kim; Gyeong-Moon Kim; Chin-Sang Chung; Kwang Ho Lee; Oh Young Bang
Journal:  J Stroke       Date:  2016-09-30       Impact factor: 6.967

7.  Early Recurrent Ischemic Lesions in Patients With Cryptogenic Stroke and Patent Foramen Ovale: An Observational Study.

Authors:  Tim Bastian Braemswig; Tatiana Usnich; Jan F Scheitz; Hebun Erdur; Jochen B Fiebach; Heinrich J Audebert; Matthias Endres; Christian H Nolte
Journal:  Front Neurol       Date:  2018-11-22       Impact factor: 4.003

8.  Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database.

Authors:  Benjamin S Wessler; David E Thaler; Robin Ruthazer; Christian Weimar; Marco R Di Tullio; Mitchell S V Elkind; Shunichi Homma; Jennifer S Lutz; Jean-Louis Mas; Heinrich P Mattle; Bernhard Meier; Krassen Nedeltchev; Federica Papetti; Emanuele Di Angelantonio; Mark Reisman; Joaquín Serena; David M Kent
Journal:  Circ Cardiovasc Imaging       Date:  2013-11-08       Impact factor: 7.792

9.  An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke.

Authors:  David M Kent; Robin Ruthazer; Christian Weimar; Jean-Louis Mas; Joaquín Serena; Shunichi Homma; Emanuele Di Angelantonio; Marco R Di Tullio; Jennifer S Lutz; Mitchell S V Elkind; John Griffith; Cheryl Jaigobin; Heinrich P Mattle; Patrik Michel; Marie-Louise Mono; Krassen Nedeltchev; Federica Papetti; David E Thaler
Journal:  Neurology       Date:  2013-07-17       Impact factor: 9.910

10.  The risk of paradoxical embolism (RoPE) study: initial description of the completed database.

Authors:  David E Thaler; Emanuele Di Angelantonio; Marco R Di Tullio; Jennifer S Donovan; John Griffith; Shunichi Homma; Cheryl Jaigobin; Jean-Louis Mas; Heinrich P Mattle; Patrik Michel; Marie-Luise Mono; Krassen Nedeltchev; Federica Papetti; Robin Ruthazer; Joaquín Serena; Christian Weimar; Mitchell S V Elkind; David M Kent
Journal:  Int J Stroke       Date:  2012-08-09       Impact factor: 5.266

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.